Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ASCENIV ™ safely and effectively. See full prescribing information for ASCENIV. ASCENIV (immune globulin intravenous, human – slra) 10% Liquid Initial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
ASCENIV is indicated for the treatment of primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. PI includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
- generic_name
- human immunoglobulin g
- product_names
- HUMAN IMMUNOGLOBULIN G
- ndc
- 69800-0250, 69800-0250-2, 69800-0250-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en